AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TENOFOVIR ALAFENAMIDE 25 Mg ;

10 registrations across 1 African market— 10 active

Markets with TENOFOVIR ALAFENAMIDE 25 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Alatenovir
Film Coated Tablets
🇪🇬EgyptEgyptian International Pharmaceutical Industries Company (EIPICO)active
Talafovir
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Alatenovir
Film Coated Tablets
🇪🇬EgyptEgyptian International Pharmaceutical Industries Company (EIPICO)active
Talafovir
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Genvoyamoun
Film Coated Tablets
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Tenofenamide 25 mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Vemlidy
Film Coated Tablets
🇪🇬EgyptEVA PHARMA Scientific Officeactive
Genvoyamoun
Film Coated Tablets
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Tenofenamide 25 mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Vemlidy
Film Coated Tablets
🇪🇬EgyptEVA PHARMA Scientific Officeactive

TENOFOVIR ALAFENAMIDE 25 Mg ; in Africa — Regulatory Overview

TENOFOVIR ALAFENAMIDE 25 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.